Primary biliary cholangitis (PBC) care
Long-term care for a condition where the immune system slowly damages the small bile ducts in the liver, using medicines to slow it down and to ease symptoms such as itching and fatigue.
✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review
In short
- PBC is a slow, long-term immune condition affecting the liver's small bile ducts; care aims to slow it and ease symptoms.
- The main medicine, ursodeoxycholic acid, controls the disease for many but not all people; response is checked at about a year.
- Itching and fatigue are common and have their own treatments, separate from slowing the disease.
- Care is lifelong, with monitoring for progression, bone health and, in cirrhosis, liver-cancer surveillance.
A plain-English summary. The detail — including risks and recovery — is below.
At a glance
A general guide. Your specialist will give you advice for your situation.
Ursodeoxycholic acid can slow the disease and improve liver blood tests in many people.
Obeticholic acid is generally avoided in advanced (decompensated) cirrhosis and can worsen itching in some people.
You begin daily ursodeoxycholic acid. Symptoms such as itching are treated separately. It may take time to feel any difference.
A clear plan to monitor liver tests and assess response at about a year.
You begin daily ursodeoxycholic acid. Symptoms such as itching are treated separately. It may take time to feel...
Liver blood tests are monitored. Itch and fatigue treatments are adjusted. Bone and vitamin checks may be arranged.
Your response is judged, mainly on ALP. If it has not improved enough, a second-line medicine may be added.
Lifelong monitoring continues, with checks for progression, bone health and, in cirrhosis, liver-cancer...
What is primary biliary cholangitis (PBC) care?
Primary biliary cholangitis (PBC) is a long-term condition in which the immune system slowly damages the small bile ducts inside the liver. Over many years this can lead to scarring (cirrhosis), but for many people the disease progresses slowly and is well controlled. It mainly affects women, often diagnosed in middle age.
Care has two aims: to slow the disease and protect the liver, and to ease symptoms such as itching, tiredness and dry eyes or mouth. The main medicine is ursodeoxycholic acid (UDCA, often called "urso"), a bile acid taken daily that protects the liver and, for many people, controls the disease.
Response is judged with blood tests, especially alkaline phosphatase (ALP), usually after about a year. If UDCA is not enough, a second-line medicine such as obeticholic acid (or, more recently, elafibranor) may be added.
This guide explains what good long-term care looks like and what to ask. It is general information, not personal medical advice; your liver specialist will tailor your plan.
Types, options & approaches
There may be different ways to do this. The right approach depends on the clinical question and your circumstances.
First-line vs second-line medicines
| Feature | Ursodeoxycholic acid | Second-line (e.g. obeticholic acid) |
|---|---|---|
| When used | First, for everyone who can take it | If UDCA does not control the disease |
| How taken | Daily tablets/capsules | Added to UDCA, or alone if UDCA not tolerated |
| Main aim | Slow disease, improve blood tests | Further improve blood tests in non-responders |
| Side effects | Usually mild | Can include itching, tiredness |
Whether you need a second-line medicine depends on your response, judged mainly on ALP blood tests.
Preparing for your treatment
- Bring details of any other autoimmune conditions (such as thyroid disease or Sjogren's) and a list of your medicines.
- Describe your symptoms clearly, especially itching, tiredness and dry eyes or mouth, so they can be addressed.
- Ask about checking your bone health and fat-soluble vitamin levels.
- Tell your clinician if you are pregnant, might become pregnant, or are breastfeeding.
- Ask how and when your response to treatment will be judged (usually ALP at about a year).
- Plan to take UDCA consistently every day, as it works gradually.
- Keep alcohol low to avoid adding to liver strain.
What happens
PBC is usually diagnosed by a liver specialist using blood tests, including liver tests and a specific antibody (anti-mitochondrial antibody, AMA), sometimes with a scan or biopsy to judge the stage. Many people are diagnosed after a routine blood test, before they have symptoms.
Treatment usually starts with ursodeoxycholic acid taken every day. Because it works gradually, your response is assessed with blood tests, especially ALP, after about a year. If your liver tests have not improved enough, a second-line medicine may be added.
Alongside this, symptoms are treated in their own right: medicines for itching, advice and checks for fatigue, and treatment for dry eyes and mouth. Bone health and vitamin levels are monitored. If you have cirrhosis, you may also need surveillance for complications.
Is this treatment right for me?
A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.
May not be suitable if…
- Obeticholic acid is generally avoided in advanced (decompensated) cirrhosis and can worsen itching in some people.
- Relying on supplements instead of UDCA will not slow the disease.
- Treatment cannot reverse cirrhosis that has already developed.
- Some medicines for itching interact with others and need spacing or specialist advice.
Delay or rearrange if…
- You are pregnant or planning pregnancy, so medicine choices can be reviewed.
- You are acutely unwell or jaundiced and need urgent assessment rather than routine clinic care.
- Key tests to confirm the diagnosis and stage have not yet been done.
- Bone health or vitamin levels need checking before longer-term planning.
Alternatives to discuss
- Second-line medicines (obeticholic acid, elafibranor, or bezafibrate in selected people) if UDCA is not enough.
- NHS specialist care as an alternative to private pathways.
- Symptom-focused care (itch, fatigue, dry eyes) alongside disease-slowing treatment.
- Liver transplant assessment for advanced disease or severe, untreatable itching.
Before you decide
Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.
What matters most to me?
Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.
What are all my options?
Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.
What would make me pause?
Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.
What happens if I do nothing today?
For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.
Benefits
- Ursodeoxycholic acid can slow the disease and improve liver blood tests in many people.
- Good control is linked to longer survival without needing a liver transplant.
- Symptoms such as itching and dry eyes can often be eased with specific treatments.
- Regular monitoring can catch progression and complications early.
- Second-line medicines give an option for people who do not respond to UDCA alone.
Risks & complications
- Mild side effects from medicines (UDCA is usually well tolerated; some weight gain can occur)
- Itching and fatigue that can be hard to control fully
- Needing lifelong daily medicine and regular blood tests
- Some people not responding fully to first-line treatment
- Itching that worsens on obeticholic acid, sometimes limiting its use
- Thinning of the bones (osteoporosis) linked to the condition
- Low levels of fat-soluble vitamins if bile flow is reduced
- Progression to cirrhosis over years in some people
- Severe, treatment-resistant itching affecting quality of life
- Advanced liver disease needing transplant assessment
- Liver cancer in those who develop cirrhosis
PBC usually progresses slowly, but it varies a lot between people, and the main uncertainties are how well you respond to UDCA and how troublesome your symptoms are. Ask how your response will be judged, what the plan is if UDCA is not enough, and how your bones, vitamins and (if you have cirrhosis) liver-cancer risk will be monitored.
Published figures to discuss
How PBC progresses, and how well it responds to treatment, varies considerably between people. A few figures are reasonably well established and are given below; precise individual outlook should be discussed with your specialist, who will use your own blood tests.
| Figure | Reported range | How to interpret it | Source / confidence |
|---|---|---|---|
| People with PBC who are women | The condition is around 10 times more common in women than men | UK-PBC/BSG guideline; PBC predominantly affects women, often in middle age. | BSG / UK-PBC treatment and management guidelines (PMC)pmc.ncbi.nlm.nih.govSource-linked context |
| Adequate disease control on ursodeoxycholic acid | Around 6 in 10 people find UDCA controls their PBC | British Liver Trust figure; the rest may need a second-line medicine, and response is judged mainly on ALP. | Guide sourcesClinical context |
| Another autoimmune condition alongside PBC | Over half of people with PBC | UK-PBC/BSG guideline; commonly thyroid disease, Sjogren's, scleroderma or coeliac disease. | BSG / UK-PBC treatment and management guidelines (PMC)pmc.ncbi.nlm.nih.govSource-linked context |
These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.
What happens afterwards
There is no single recovery point, because this is long-term care. "Afterwards" means how your liver tests respond to treatment over the first year, and the ongoing monitoring needed to keep things stable.
- A gradual improvement in liver blood tests over months for many people
- Itching and fatigue that may persist and need their own treatment
- Feeling generally well, especially when diagnosed early
- Needing ongoing medicine and monitoring rather than a one-off cure
Aftercare
- Take ursodeoxycholic acid every day as prescribed; it works gradually.
- Attend regular blood tests so your response and liver health can be tracked.
- Tell your clinician about troublesome itching, fatigue or dry eyes so they can be treated.
- Follow advice on bone protection and any vitamin supplements.
- Keep alcohol low and look after general liver health.
- Keep up recommended vaccinations and general health checks.
- Know who to contact if you develop jaundice or feel unwell.
- Daily ursodeoxycholic acid prescription arranged
- Date set to review response (ALP) at about 12 months
- Itch and fatigue treatments discussed if needed
- Bone-health and vitamin monitoring arranged
- Liver-cancer surveillance arranged if cirrhosis is present
- Out-of-hours contact saved in case of warning signs
⚠ Get urgent help if…
- Yellowing of the skin or eyes (jaundice) that is new or worsening
- Severe, unrelenting itching that disturbs sleep
- Dark urine, pale stools or severe tummy pain
- New confusion, drowsiness or marked swelling of the tummy or legs
- Vomiting blood or passing black, tarry stools - call 999
- Fever or feeling very unwell with right-sided tummy pain
Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.
General guidance — it doesn't replace the specific advice your specialist gives you.
Results & realistic expectations
A good result is liver blood tests, especially ALP, that improve and stabilise on treatment, alongside symptoms that are kept manageable. For many people, PBC can then be a slowly progressing, well-controlled condition.
What treatment cannot do is cure PBC or guarantee no progression. Some people respond only partly to UDCA, and a minority go on to develop cirrhosis despite treatment. That is why response is checked, second-line options exist, and monitoring continues for life.
For many people, especially those who respond well to UDCA, PBC progresses slowly and life expectancy can be near-normal. Response to treatment, judged on blood tests, is one of the strongest guides to outlook. Because the condition can change over years, the plan is reviewed regularly, and people who do not respond fully are considered for additional treatment.
Related tests, treatments or support
PBC often occurs with other autoimmune conditions, such as thyroid disease or Sjogren's syndrome (dry eyes and mouth), which are managed alongside it. Where there are overlapping features with autoimmune hepatitis, treatment is tailored to the combined picture. Bone health and vitamin levels are managed as part of routine care.
Follow-up & long-term care
Follow-up is lifelong. Liver blood tests are monitored regularly, with a key assessment of response at about 12 months. Bone health and vitamin levels are checked periodically. People with cirrhosis also need surveillance for complications, including six-monthly liver-cancer surveillance.
- Daily ursodeoxycholic acid, usually for life
- Regular liver blood tests, with a formal response check at about 12 months
- A second-line medicine added if response is inadequate
- Monitoring and treatment of bone health and fat-soluble vitamins
- Ongoing treatment of itching and fatigue as needed
- Liver-cancer surveillance if cirrhosis develops
Repeat, follow-on and what comes next
- Treatment is adjusted over time based on response, with second-line medicines added if needed.
- Symptom treatments (for itch or fatigue) are often changed until something suits.
- A minority progress to cirrhosis and move into surveillance and, rarely, transplant assessment.
Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.
What good aftercare looks like
- A clear plan to monitor liver tests and assess response at about a year.
- Active treatment of itching, fatigue and dryness, not just the liver tests.
- Bone-health and vitamin monitoring built into care.
- Liver-cancer surveillance arranged if cirrhosis develops.
- A named contact and clear advice on when to seek help.
What affects the cost
Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:
- Specialist consultations and how often you are reviewed
- Diagnostic tests, including blood tests and sometimes a scan or biopsy
- Regular blood-test monitoring, including the response check at about a year
- The medicines used (first-line UDCA, and any second-line medicine)
- Treatments for itching and fatigue, and dry eyes or mouth
- Bone-health and vitamin monitoring, and surveillance if cirrhosis develops
- The specialist's consultation and follow-up fees
- Costs of diagnostic and monitoring blood tests, and how often
- The cost of first-line and any second-line medicines, and repeat prescriptions
- Whether symptom treatments (itch, dry eyes) are included
- Whether bone-health and vitamin monitoring is covered
- What happens, and who pays, if you do not respond or develop a complication
On the NHS? Primary biliary cholangitis is routinely managed on the NHS, including second-line medicines and transplant assessment where needed; private care is mainly used for speed, choice of clinician or a second opinion.
You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.
Consent traps and marketing red flags
These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.
Consent traps
- Being told UDCA is a cure rather than a disease-slowing treatment.
- Itching and fatigue dismissed rather than treated in their own right.
- No plan to assess response at about a year, or to consider second-line treatment.
- Bone health and fat-soluble vitamins not monitored.
- No liver-cancer surveillance once cirrhosis is present.
Marketing red flags
- Claims that a supplement, detox or diet can cure PBC.
- Offering treatment without monitoring response on blood tests.
- Ignoring symptoms such as itching that have specific treatments.
- Promising to reverse cirrhosis.
Choosing a specialist safely
- Check the specialist is on the GMC Specialist Register for this area.
- Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
- You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
- Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
- You're entitled to your total cost in writing — including any follow-up — before you decide.
Questions to ask your medical professional
Take this to your consultation. A good specialist will welcome every one of these.
- How is my PBC responding to treatment, based on my blood tests?
- If ursodeoxycholic acid is not enough, what second-line options do I have?
- What can be done to control my itching or fatigue?
- How will my bone health and vitamin levels be monitored?
- Do I have any liver scarring, and if so will I need liver-cancer surveillance?
- Are there other autoimmune conditions I should be checked for?
- Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
- Will you be the specialist who carries out my treatment, and who looks after me afterwards?
- What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
- What does a realistic result look like — and what can this treatment not achieve?
- What are my options, including waiting, doing nothing for now, or choosing a different approach?
- Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
- What is the total cost in writing, including any follow-ups, and how much time do I have to decide?
Frequently asked questions
Is PBC the same as cirrhosis?
Will ursodeoxycholic acid cure my PBC?
What can be done about the itching?
Why am I so tired?
Is treatment available on the NHS?
Do I need treatment if I feel fine?
Find a verified specialist for primary biliary cholangitis (pbc) care
Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.
No verified consultants list this procedure yet — browse the full directory.
How we made this page
Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →
Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.
Sources & standards: British Liver Trust - Treating primary biliary cholangitis BSG / UK-PBC treatment and management guidelines (PMC) NICE TA443 - Obeticholic acid for treating primary biliary cholangitis British Liver Trust - New PBC treatment approved by NICE (elafibranor) Treatment in PBC: beyond ursodeoxycholic acid - review (EJIM)
Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.
Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.
Related guides: Autoimmune hepatitis care · Primary sclerosing cholangitis (PSC) care · Alcohol-related liver disease care · Cirrhosis management and monitoring · Haemochromatosis (iron overload) management